 |
 |

New Presenilin 1 Mutation With Alzheimer Disease and Lewy Bodies
Arch Neurol. 2005;62:1808.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
The rare families with early-onset Alzheimer disease (AD) and autosomal dominant inheritance have been important in elucidating mutations in the presenilin 1 (PS1) and 2 genes and in the amyloid precursor protein gene that cause disease.1 These 3 gene mutations underscore the critical importance of normal amyloid precursor protein processing and the fact that a 50% increase in the amount of amyloid- peptide (A 42) produced as a result of these mutations is sufficient to cause increased accumulation of A 42, which in part causes the early and severe dementia. Abnormal amyloidogenesis is the predominant hypothesis to explain increased A 42 burden in the brain of patients with AD and the resultant dementia.1 Another major unresolved issue in understanding the genetic and molecular basis of AD is the role of Lewy bodies, composed mainly of -synuclein. Brains affected by AD may contain significant levels of Lewy bodies diffusely in neocortical and . . . [Full Text of this Article]AUTHOR INFORMATION
Roger N. Rosenberg, MD, Editor
RELATED ARTICLE
Novel Presenilin 1 Mutation (S170F) Causing Alzheimer Disease With Lewy Bodies in the Third Decade of Life
B. Joy Snider, Joanne Norton, Mary A. Coats, Sumi Chakraverty, Craig E. Hou, Ramiro Jervis, Corinne L. Lendon, Alison M. Goate, Daniel W. McKeel, Jr, and John C. Morris
Arch Neurol. 2005;62(12):1821-1830.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Enhanced Accumulation of Phosphorylated {alpha}-Synuclein and Elevated -Amyloid 42/40 Ratio Caused by Expression of the Presenilin-1 {Delta}T440 Mutant Associated with Familial Lewy Body Disease and Variant Alzheimer's Disease
Kaneko et al.
J. Neurosci. 2007;27:13092-13097.
ABSTRACT
| FULL TEXT
|